Co-Diagnostics (CODX) Competitors $0.42 -0.02 (-4.22%) Closing price 09/22/2025 04:00 PM EasternExtended Trading$0.40 -0.01 (-3.43%) As of 08:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CODX vs. SRTS, MDAI, GUTS, APT, WOK, MLSS, NEPH, ZYXI, NMTC, and PSTVShould you be buying Co-Diagnostics stock or one of its competitors? The main competitors of Co-Diagnostics include Sensus Healthcare (SRTS), Spectral AI (MDAI), Fractyl Health (GUTS), Alpha Pro Tech (APT), WORK Medical Technology Group (WOK), Milestone Scientific (MLSS), Nephros (NEPH), Zynex (ZYXI), NeuroOne Medical Technologies (NMTC), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry. Co-Diagnostics vs. Its Competitors Sensus Healthcare Spectral AI Fractyl Health Alpha Pro Tech WORK Medical Technology Group Milestone Scientific Nephros Zynex NeuroOne Medical Technologies Plus Therapeutics Co-Diagnostics (NASDAQ:CODX) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends. Is CODX or SRTS more profitable? Sensus Healthcare has a net margin of -2.26% compared to Co-Diagnostics' net margin of -3,588.33%. Sensus Healthcare's return on equity of -1.58% beat Co-Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Co-Diagnostics-3,588.33% -69.49% -60.49% Sensus Healthcare -2.26%-1.58%-1.41% Which has better earnings and valuation, CODX or SRTS? Sensus Healthcare has higher revenue and earnings than Co-Diagnostics. Sensus Healthcare is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCo-Diagnostics$3.91M4.13-$37.64M-$1.15-0.36Sensus Healthcare$41.81M1.24$6.65M-$0.06-52.50 Do institutionals & insiders have more ownership in CODX or SRTS? 15.0% of Co-Diagnostics shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 6.1% of Co-Diagnostics shares are held by insiders. Comparatively, 8.9% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor CODX or SRTS? In the previous week, Co-Diagnostics had 3 more articles in the media than Sensus Healthcare. MarketBeat recorded 6 mentions for Co-Diagnostics and 3 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.14 beat Co-Diagnostics' score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Co-Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sensus Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer CODX or SRTS? Co-Diagnostics presently has a consensus price target of $5.50, suggesting a potential upside of 1,211.40%. Sensus Healthcare has a consensus price target of $8.00, suggesting a potential upside of 153.97%. Given Co-Diagnostics' higher probable upside, research analysts plainly believe Co-Diagnostics is more favorable than Sensus Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Co-Diagnostics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, CODX or SRTS? Co-Diagnostics has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500. SummarySensus Healthcare beats Co-Diagnostics on 11 of the 16 factors compared between the two stocks. Get Co-Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CODX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CODX vs. The Competition Export to ExcelMetricCo-DiagnosticsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.87M$7.89B$5.79B$10.46BDividend YieldN/A2.78%5.61%4.57%P/E Ratio-0.36164.55348.7026.86Price / Sales4.1374.00555.22125.65Price / CashN/A25.3826.0131.15Price / Book0.2547.9515.906.50Net Income-$37.64M$241.92M$3.29B$271.25M7 Day Performance-34.35%75.04%200.40%3.27%1 Month Performance31.51%47.93%184.30%8.15%1 Year Performance-65.34%37.18%330.38%26.52% Co-Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CODXCo-Diagnostics3.8695 of 5 stars$0.42-4.2%$5.50+1,211.4%-67.5%$16.87M$3.91M-0.36100Gap DownSRTSSensus Healthcare2.9387 of 5 stars$3.15-0.9%$8.00+154.0%-45.7%$52.28M$37.56M-52.5040Positive NewsGap DownMDAISpectral AI2.946 of 5 stars$1.99+2.6%$3.50+75.9%+123.8%$51.86M$27.55M-2.8883Gap UpGUTSFractyl Health2.765 of 5 stars$0.98-3.7%$7.15+628.1%-64.5%$51.30M$17K-0.48102High Trading VolumeAPTAlpha Pro Tech1.6019 of 5 stars$4.84-1.0%N/A-19.8%$50.69M$58.56M13.08120Positive NewsWOKWORK Medical Technology GroupN/A$0.80flatN/A-81.1%$45.60M$11.51M0.00226News CoverageGap DownHigh Trading VolumeMLSSMilestone Scientific2.638 of 5 stars$0.58-1.6%$1.25+115.4%-52.8%$45.59M$9.08M-8.2930News CoverageGap DownNEPHNephros3.232 of 5 stars$4.36+2.3%$5.50+26.1%+134.2%$45.16M$14.16M36.3330High Trading VolumeZYXIZynex1.8494 of 5 stars$1.48flat$4.90+231.1%-80.5%$44.84M$192.35M-1.57770NMTCNeuroOne Medical Technologies2.2449 of 5 stars$0.88-1.0%$2.23+152.8%+0.9%$44.46M$6.63M-5.8720PSTVPlus Therapeutics3.2016 of 5 stars$0.41-7.7%$7.88+1,807.2%-74.2%$44.40MN/A-0.1820News CoverageGap Up Related Companies and Tools Related Companies SRTS Competitors MDAI Competitors GUTS Competitors APT Competitors WOK Competitors MLSS Competitors NEPH Competitors ZYXI Competitors NMTC Competitors PSTV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CODX) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Co-Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Co-Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CODX Stock Alerts